Overview
Thomas Hogan is a Hematologist Oncology specialist and an Oncologist in Morgantown, West Virginia. Dr. Hogan is rated as an Advanced provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, and Renal Cell Carcinoma (RCC).
His clinical research consists of co-authoring 11 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles and participated in 1 clinical trial in the study of Bladder Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- MEDICARE PDP
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1 Medical Ctr Dr, Morgantown, WV 26506
Additional Areas of Focus
Dr. Hogan has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
UPMC Department Of Urology
Bruce L. Jacobs, MD, is an associate professor of urology at the University of Pittsburgh School of Medicine. He received a medical degree from the Vanderbilt University School of Medicine in Nashville, Tenn., and earned a master’s degree in public health from the University of Michigan School of Public Health. Dr. Jacobs completed residencies in general surgery and urology at the University of Pittsburgh, and fellowships in health services research, laparoscopy/endourology, and urologic oncology at the University of Michigan. Dr. Jacobs is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Prostate Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Prostatectomy.
UPMC Department Of Urology
Tatum V. Tarin, MD, is an Associate Professor of Urology at the University of Pittsburgh School of Medicine. He earned his medical degree from the University of Pittsburgh, and completed residencies in surgery and urology at Stanford University Medical Center. He also completed a fellowship in urological oncology at Memorial Sloan-Kettering Cancer Center in New York, N.Y., where he was a clinical instructor for two years prior to joining UPMC. Dr. Tarin is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Lymphadenectomy, and Nephrectomy.
University Of Pittsburgh Physicians
Leonard Appleman is a Hematologist Oncology specialist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Appleman is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, and Chromophobe Renal Cell Carcinoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adult Soft Tissue SarcomaDr. Hogan isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Chromophobe Renal Cell CarcinomaDr. Hogan isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Hogan isDistinguished. Learn about Clear Cell Sarcoma.
- Familial Prostate CancerDr. Hogan isDistinguished. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Hogan isDistinguished. Learn about Familial Wilms Tumor 2.
- Muscle Invasive Bladder CancerDr. Hogan isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Advanced
- Adrenal CancerDr. Hogan isAdvanced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Hogan isAdvanced. Learn about Adrenocortical Carcinoma.
- Bladder CancerDr. Hogan isAdvanced. Learn about Bladder Cancer.
- Familial Colorectal CancerDr. Hogan isAdvanced. Learn about Familial Colorectal Cancer.
- MethemoglobinemiaDr. Hogan isAdvanced. Learn about Methemoglobinemia.
- Upper Tract Urothelial Carcinoma (UTUC)
- Experienced
- 2q37 Deletion SyndromeDr. Hogan isExperienced. Learn about 2q37 Deletion Syndrome.
- 47 XYY SyndromeDr. Hogan isExperienced. Learn about 47 XYY Syndrome.
- Aase SyndromeDr. Hogan isExperienced. Learn about Aase Syndrome.
- Abruzzo-Erickson SyndromeDr. Hogan isExperienced. Learn about Abruzzo-Erickson Syndrome.
- Acrodermatitis EnteropathicaDr. Hogan isExperienced. Learn about Acrodermatitis Enteropathica.
- Acrorenal Mandibular SyndromeDr. Hogan isExperienced. Learn about Acrorenal Mandibular Syndrome.